Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Kirin Holdings Co Ltd    2503   JP3258000003

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Kirin Holdings Co., Ltd. is engaged in the manufacture and sale of beverages and pharmaceutical products. It operates through the following segments: Domestic Alcohol, Domestic Beverages, Foreign Liquor and Beverages, Pharmaceuticals and Biochemicals, and Others. The Domestic Alcohol segment... 
Sector
Brewers
Calendar
11/07Earnings Release
Surperformance© rating of Kirin Holdings Co Ltd
Trading Rating : Investor Rating :
More about the company
Chart KIRIN HOLDINGS CO LTD
Duration : Period :
Kirin Holdings Co Ltd Technical Analysis Chart | 2503 | JP3258000003 | 4-Traders
Full-screen chart
Financials ( JPY)
Sales 2014 2 254 522 M
EBIT 2014 133 260 M
Net income 2014 50 303 M
Debt 2014 674 878 M
Yield 2014 2,74%
Sales 2015 2 277 119 M
EBIT 2015 148 071 M
Net income 2015 62 415 M
Debt 2015 625 902 M
Yield 2015 2,97%
PER 2014 25,76
PER 2015 20,82
EV / Sales 2014 0,90x
EV / Sales 2015 0,87x
Capitalization 1 344 245 M
More Financials
Latest news on KIRIN HOLDINGS CO LTD
2d ago Kyowa Hakko Kirin Announces Commencement of Phase 2b Clinical Study of KHK758..
08/07 NOVO : Prostrakan deal completed
08/05 KIRIN : Mercians off on UN duty to patrol zone that divides Cyprus
07/29 KYOWA HAKKO KIRIN : KIRIN -Announcement of Start of Phase 1 Joint Japanese-Korea..
07/28 KIRIN : Notice Concerning Sale of Shares Held by Untraceable Shareholders
07/12 KIRIN : ProStrakan swoops on rival to hasten growth in Europe
07/08 KYOWA KIRIN -Topical Combination Drug Dovobet Ointment Approved to Treat Psor..
07/03 KYOWA HAKKO KIRIN : Future Development Direction for Bardoxolone Methyl (RTA 402..
07/01 KYOWA HAKKO KIRIN : Reapplication Seeking Approval for Additional Indication for..
06/26 KIRIN HOLDINGS COMPANY, LIMITED. : ex-dividend day for interim dividend
06/25 KYOWA HAKKO KIRIN : Announcement of Results from a Multiple Dose Phase 1/2 Study..
06/24 ULTRAGENYX PHARMACEUTICAL : Announces Results From Phase 1/2 Study of KRN23 in X..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
Kirin Holdings Co Ltd : Income Statement Evolution
More Financials
EPS Revisions
Kirin Holdings Co Ltd : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF